Церебральный вазоспазм после субарахноидальной геморрагии. Молекулярные аспекты эндотелиальной дисфункции (обзор литературы)

Yuriy Zozulya; L. Senko

Authors

Yuriy Zozulya Romodanov Neurosurgery Institute, Kiev, Ukraine https://orcid.org/0000-0002-0573-2740
L. Senko Romodanov Neurosurgery Institute, Kiev, Ukraine

Keywords:

cerebral vasospasm, subarachnoid hemorrhage, endothelial dysfunction, endothelin, nitric oxide donor NO, intrathecal

Abstract

The pathogenesis of cerebral vasospasm (CV) after subarachnoid hemorrhage (SAН) is multifactoral. Severe CV after SAH is prolonged contraction that leads to cerebral ischemia or infarction. Although have been many studies on cerebral vasospasm after SAH, the optimal treatment CV has not yet been established. In this review we have attempt to discussed many factors have been implication in the pathogenesis CV and mechanisms of dysfunction vasocontriction/vasodilation during SAH–induced CV and to present the general situation in the field of CV after SAH treatment.

References

Зозуля Ю.А., Сенько Л.Н. Мультифункциональность и метаболизм оксида азота в центральной нервной системе // Журн. АМН України. — 2000. —№1. — С.3—25.

Карпюк В.Б., Черняк Ю.С., Шубич М.Г. Постгеморрагический церебральный вазоспазм в свете современных представлений о регуляции мозгового кровообращения // Вопр. нейрохирургии. — 2000. — №1. —С.30—34.

Крылов В.В., Гусев А.С. Сoсудистый спазм при разрыве аневризм головного мозга // Нейрохирургия. — 2000. — №3. —С.4—13.

Adams M.R., Jessup W., Hailstones D. et al. L–arginine reduces monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules // Circulation. — 1997. — V.95. — P.662—668.

Adams M.R., McCredie R., Jessup W. et al. Oral L–arginine improves endothelium–dependent dilatation and reduces monocyte adhesion to endothelial cell cn young men with coronary artery disease // Atherosclerosis. — 1997. — V.129. — P.261—269.

Afshar J.K.B., Pluta R.M., Book R.J. et al. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage // J. Neurosurg. —1995. — V.83. —P.118—122.

Akli S., Caillaund C., Vigne S. et al. Transfer of foreigh gene into the brain using adenovirus vector // Nat Genet. — 1993. — V.3. — P.224—228.

Alabadi J., Torregrosa G., Miranda F.J. et al. Impairment of the modulatory Role of Nitric Oxide on the Endothelin-1-elicited Contraction of Cerebral Arteries: A pathogenetic Factor in Cerebral Vasospasm after Subarachnoid Hemorrhage? // Neurosurgery. — 1997. — V.41(1). — P.245—253.

Arai H., Hori S., Aramori J. et al. Cloning and expression of cDNA encoding an endothelin receptor // Nature. — 1990. — V.348. —P.730—732.

Asano T., Matsui T. Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage // Cell. Mol. Neurobiol. — 1999. V.19(1). — P.31—44.

Bejjani G.K., Duong D.H., Kalamarides M. et al. Cerebral vasospasm after tumor resection. A case report // Neurochirurgie. — 1997. — V.43 (3). —P.164—168.

Bejjani G.K., Sekhar L.N., Yost A.M. et al. Vasospasm after cranial base tumor resection: pathogenesis, diagnosis, and therapy // Surg. Neurol. — 1999. — V.52 (6). — P.577—584.

Borger M.A., Weisel R.D. Calcium channel blockers in myocardial and cerebral ischemia: a clinician’s review from bench to bedside // Can. J. Cardiol. — 1999. — V.15 (3). — P.333—340.

Chen A.F., Jiang S.W., Crotty T.B. et al. Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries // Proc. Natl. Acad. Sci. USA. — 1997. — V.94. — P.12568—12573.

Christenson S.D., Lake K.D., Ooboshi H. Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue in mice // Stroke. — 1998. — V.29. — P.1411—1416.

Cloft H.J., Shengelaia G. Transluminal ballon angioplasty for prevention of vasospasm // J. Neurosurg. —2000. — V.2 (2). — P.369—371.

Clozel M., Gray G.A., Breu V. et al. The endothelin ETB receptor mediates both vasodilatation and vasoconstriction in vivo // Biochem. Biophys Res. Commun. — 1992. — V.186. — P.867—73.

Culotta E., Koshland D.E. NO: Molecule of the Year //Science. — 1992. — V.258. — P.1862—1865.

Dorsch N.W.C., King M.T. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage // J. Clin. Neuroscience. — 1994. — V.1. — P.19—26.

Egelmen N., Turker R.K., Sanlidilek U. et al. The effect of intrathecal sodium nitroprusside on severe chronic vasospasm // Neurol. Rev. — 1993. — V.15. — P.310—315.

Faraci F.M., Brian J.E. Nitric oxide and the cerebral circulation // Stroke. — 1994. — V.25. —P.692—703.

Faraci F.M., Brian J.E. 7–Nitroindazole in hibits brain nitric oxide synthase and cerebral vasodilatation in response to N-methyl-D-aspartate // Stroke. — 1995. V.26. — P.2172—2175.

Faraci F.M., Heistad D.D. Regulation of the cerebral circulation: role of endothelium and potassium channels // Physiol.Rev. — 1998. — V.78(1). — P.53—97.

Fein J.M., Flor W.J., Cohan S.L., Parkhurst J. Sequential changes of vascular ultrastructure in experimental cerebral vasospasm. Myonecrosis of subarachnoid arteries // J. Neurosurg. — 1974. — V.41. — P.49—58.

Findlay J.M., Macdonald R.L., Weir B.K. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage // Cerebrovasc. Brain Metab. Rev. — 1997. — V.3. — P.336—361.

Fisher C.M., Kistler J.R., Davis J.M. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning // Neurosurgery. — 1980. —V.6. — P.1—9.

Fujiwara N., Honjo Y., Ohkawa M. et al. Intraarterial infusion of papaverine in experimental cerebral vasospasm // AJNR Am. J. Neuroradiol. — 1997. — V.18 (2) — P.255—262.

Fuwa I., Mayberg M., Gadjusk C. et al. Enhanced secretion of endothelin by endothelial cells in response to hemoglobin // Neurol. Med. Chir. (Tokyo). — 1997. — V.33. — P.739—746.

Geng Y.J. Regulation of programmed cell death or apoptosis in atherosclerosis // Heart Vessels. — 1997. — Suppl. 12. — P.76—80.

Harrison D.G. Endothelial dysfunction in atherosclerosis // Basis. Res. Cardiol. —1994. — V.89, suppl.1. — P.87—102.

Hatake K., Wakabayashi I., Kakishita E., Hishida S. Impairment of endothelium-dependent relaxation in human basilar artery after subarachnoid hemorrhage // Stroke. — 1992. — V.23. — P.1111—1117.

Henry Y., LePoivre M., Drapier J.C. et al. EPR characterization of molecular targets for NO in mamalian cells and organelles // FASEB J. —1993. —V.7. — P.1124—1134.

Hino A., Tokuyama Y., Kobayashi M. et al. Increased expression of endothelin B receptor mRNA following subarachnoid hemorrhage in monkeys // J. Cereb. Blood. Flow. Metab. —1996. — V.16. — P.688—697.

Hirashima Y., Nakamura S., Endo S. et al. Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage // Neurochem. Res. — 1997. — V.22. —P.1249—1255.

Hongo K., Kassell N.F., Nakagomi T. et al. Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery // J. Neurosurg. — 1988. — V.69. — P.247—253.

Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide // Proc. Natl. Acad. Sci. USA. — 1987. — V.84. — P.9265—9269.

Ito Y., Isotani E., Mizuno Y. et al. Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin // J. Cardiovasc. Pharmacol. — 2000. — V.35 (1). — P.45—50.

Kasuya H., Weir B.K., White D.M., sStefansson K. Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smoth-muscle cells // J Neurosurg. — 1993. — V.79. — P.892—898.

Katussicc Z.C., Cosentino F. Nitric oxide synthase: from molecular biology to cerebrovascular physiology// News. Physiol. Sci. — 1994. —V.9. — P.64—67.

Kim P., Sundt T.M., Vanhoutte P.M. Alterations in endothelium-dependent responsiveness of the canine basilar artery after subarachnoid hemorrhage // J. Neurosurg. — 1988. — V.69. — P.239—246.

Kim P., Schini V.D., Sundt T.M., Vanhoutte P.M. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage // Circ. Res. — 1992. — V.70. — P.248—256

Kikkawa K., Saito A., Iwasaki H. et al. Prevention of cerebral vasospasm by novel endothelin receptor antagonist TA-0201 // J. Cardiovasc. Pharmacol. — 1999. — V.34 (5). — P.666—673.

Kiris T., Karasu A., Yovuz C. et al. Reversal of cerebral vasospasm by the nitric oxide donor SNAP in the experimental model of subarachnoid hemorrhage // Acta. Neurochir. (Wien). — 1999. — V.141 (12). — P.1323—1329.

Lee M.E., dela Monte S.M., Ng S.C. et al. Expression of the potent vasoconstrictor endothelin in the human central nervous system // J. Clin. Invest. — 1990. — V.86. — P.141—47.

Leyen H.E., Gibbons G., Morishita R. et al. Gene therapy inhibing neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene // Proc. Natl. Acad. Sci. USA. — 1995. — V.92. — P.1137—1141.

Levati A., Solaini C., Boseli L. Prevention and treatment of vasospasm // J. Neurosurg. Sci. — 1998. — V.42, suppl. 1. — P.27—31.

Malinsky T., Radomski M.W., Faha Z., Moncada S. Direct electrochemical measurement of nitric oxide released from human platelets // Biochem. Biophys. Res. Commun. — 1993. — V.194. — P.960-965.

Martin W., Viliani G.M., Jothianandan, Furchgott R.F. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta // J. Fharmacol. Exp. Ther. — 1985. — V.232. — P.708—716.

Martin N.A., Patwardhan R.V., Alexander M.I. et al. Characterization of cerebral hemodynamic phases following severe heat trauma: hypoperfusion, hyperemia, and vasospasm // J. Neurosurg.— 1997. — V.87. — P.9—19.

Mayberg M.R., Okada T., Bark D.H. The role of hemoglobin in arterial narrowing after subarachnoid hemorrhage // J. Neurosurg. — 1990. — V.72. — P.634—640.

McCown T.J., Xiao X., Li J. et al. Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue in mice // Stroke. — 1996. — V.29. — P.1411—1116.

McCumber M.W., Ross C.A., Snyder S.H. Endothelin in brain: Receptors, mitogenesis and biosynthesis in glial cells // Proc. Natl. Acad. Sci. USA. — 1990. — V.87. — P.2359—2363.

Medele R.J., Stummer W., Reulen H.J., Steigen H.J. Evidence for peroxidative damage by nitric oxide in experimental chronic cerebral vasospasm // Neurol. Res. — 1996. — V.18(3). — P.277—280.

Megyesi J.F., Vollrath B., Cook D.A., Findlay J.M. In vivo animal models of cerebral vasospasm: a review // Neurosurgery. — 2000. — V.46(2). —P.448—460.

Moncada S., Palmer P.M.J., Higgs A. Biosynthesis of nitric oxide from L-arginine: A pathway for the regulation of cell function and communication // Biochem Pharmacol. — 1989. — V.38. — P.1709—1715.

Montessuit M., Chevalley C., King J., Faidutti B. The use of intra-aortic counterpulsation ballon for the treatment of cerebral vasospasm and edema // Surgery. — 2000. — V.127 (2). — P.230—233.

Mori T., Katayama Y., Kawamata T., Hirayama T. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage // J. Neurosurg. — 1999. — V.91 (6). — P.947—952.

Nakao K., Murata H., Kanamaru K., Waga S. Effect of nitroglycerine on vasospasm and cyclic nucleotides in a primate model of subarachnoid hemorrhage // Stroke. — 1996. — V.27. — P.1882—1888.

Newell D.W., Elliott J.P., Eskridge J.M., Winn H.R. Endovascular therapy for aneurysmal vasospasm // Crit. Care. Clin. — 1999. — V.15 (4). — P.685—699.

Ohta K., Rosner G. and Graf. R Nitric Oxide Generation from Sodium Nitroprusside and Hydroxylamine in Brain // Neur.Report. — 1997. — V.8. — P.2229—2235.

Ohta K., Graf R., Rosner G., Heiss W-D. Profiles of Cortical Tissue Depolarization in Cat Focal Cerebral Ischemia in Relation to Calcium Ion Homeostasis and Nitric Oxide Production // J. Cerebral Blood Flow and Metabolism. — 1997. — V.17. — P.1170-1181.

Onoda K., Shigcki O., Ogehara K. et al. Inhibition of vascular contraction by intracirternal administration of preproendothelin-1 mPNA antisense oligo-DNA in a rat experimental vasospasm model // J. Neurosurg. — 1996. — V.85. — P.846—852.

Onoue H., Kaito N., Akiyama M. et al. Altered reactivity of human cerebral arteries after subarachnoid hemorrhage // J. Neurosurg. — 1995. — V.85. — P.510—515.

Onoue H., Tsutsui M., Smith L. et al. Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage // Stroke. — 1998. — V.29 (9). — P.1959—1966.

Palmer R.M.J., Ferrige A.C., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor // Nature. — 1987. — V.327. — P.524—526.

Peltonen S., Juvela S., Kaste M., Lassila R. Hemostasis and fibrinolysis activation after subarachnoid hemorrhage // J. Neurosurg. — 1997. — V.87. — P.207—214.

Pluta R.M., Boock R.J., Afshar J.K. et al. Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage // J. Neurosurg. — 1997. — V.87 (2). — P.287—293.

Pluta R.M., Oldfield E.H., Boock R.J. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage // J. Neurosurg. — 1997. — V.87 (5). — P.746—751.

Pluta R.M., Afshar J.K., Thompson B.G. et al. Increased cerebral blood flow but no reversal or response to L-arginine infusion after subarachnoid hemorrhage // J. Neurosurg. — 2000. — V.92 (1). — P.121—126.

Quilley J., Fulton D., Mc Giff J.C. Hyperpolarizing factors // Biochem. Pharmacol. — 1997. — V.54(10). — P.1059—1070.

Radomski M.W., Palmer R.M.Y., Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation // Proc. Natl. Acad. Sci. USA. — 1990. — V.87. — P.5193-5197.

Roux S., Loffler B.M., Gray G.A. The role of endothelin in experimental cerebral vasospasm // Neurosurgery. — 1995. — V.37. — P.78—86.

Ryba M.S., Gordon-Krajcer W., Walski M. et al. Hydroxylamine attenuate the effects of simulated subarachnoid hemorrhage in the rat brain and improves neurological outcome // Brain Res. — 1999. — N.11, V.850 (1-2). — P.225—233.

Salom J.B., Torregrosa G., Alborch E. Endothelins and the cerebral circulation // Cerebrovasc. Brain Metab. Rev. — 1995. — V.7. — P.131—152.

Sawada M., Hashimoto N., Tsukahara T. et al. Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm // Acta Neurochir. (Wien). — 1997. — V.139 (8). — P.706—711.

Song J.K., Elliott J.P., Eskridge J.M. Neuroradiologic diagnosis and treatment of vasospasm // Neuroimaging Clin. N. Am. — 1997. — V.7 (4). — P.819—835.

Stoodley M., Weihl C.C., Zhang L. et al. Effect of Adenovirus-mediated Nitric Oxide Synthase Gene Transfer on Vasospasm after Experimental Subarachnoid Hemorrhage // Neurosurgery. — 2000. — V.46 (5). — P.1193—1203.

Suzuki J., Komatsu S., Sato T., Sakurai Y. Correlation between CT finding and subsequent development of cerebral infarction due to vasospasm in subarachnoid hemorrhage // Acta Neurochir. — 1980. — V.50. — P.63—70.

Suzuki R., Masaoka H., Hirata Y. et al. The role of endothelin-1 inthe origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage // J. Neurosurg. — 1992. — V.77. — P.96—100.

Suzuki M., Asahara H., Endo S. et al. Increased levels of nitrite/nitrate in the cerebrospinal fluid of patients with subarachnoid hemorrhage // Neurosurg. Rev. — 1999. — V.22 (2—3). — P.96—100.

Suzuki K., Meguro K., Sakurai T. et al. Endothelin-1 Concentration Increases in the Cerebrospinal Fluid in Cerebral Vasospasm Caused by Subarachnoid Hemorrhage // Surg. Neurol. — 2000. — V.53. — P.131—135.

Thomas J.E., Nemirovsky A., Zelman V., Giannotta S.Z. Rapid Reversal of Endothelin-1-induced Cerebral Vasoconstriction by Intrathecal Administration of Nitric Oxide Donors // Neurosurgery. — 1997. — V.40 (6). — P.1245—1249.

Thomas J.E., Rosenwasser R.H. Reversal of Severe Cerebral Vasospasm in Three Patients after Aneurysmal Subarachnoid Hemorrhage: Initial Observations Regarding the Use of Intraventricular Sodium Nitroprusside in Humans // Neurosurgery. — 1999. — V.44 (1). — P.48—58.

Thomas P.C., Simonson M.S., Dunn M.J. Endothelin: receptors and transmembrane signals // TIPS. — 1992. — V.7. — P.207—211.

Tsao P.S., Buitrago R., Chan J. et al. Fluid flow inhibits endothelial adhesivenes // Circulation. — 1996. — V.94. — P.1682—1689.

Tsukahara H., Cordienko D.V., Goligorsky M.S. Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem and Biophys // Res. Comm. — 1993. — V.193 (2). — P.722—729.

Tsukahara H., Ende H., Magazine H. et al. Molecular and Functional characterization of the Non-isopeptide-selective ETB Receptor in Endothelial Cells // J. Biol. Chem. — 1994. — V.269 (34). — P.21778—21785.

Williams K.J., Tabas I. The response – to – retention hypothesis of atherogenesis reinforced // Curr. Opin. Lipidol. — 1998. — V.9. — P.471—474.

Wolf E.W., Banerjce A., Soble-Smith J. et al. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor // J. Neurosurg. — 1998. — V.89 (2). — P.279—288.

Zhang J., Lewis A.I., Bernanke D.H. et al. Stroke: anatomy of catastrophic event // The Anat. Rec. (New Anat.). — 1998. — V.253. — P.58—63.

Zimmermann M., Seifert V. Endothelin and Subarachnoid Hemorrhage. An Overview // Neurosurgery. — 1998. — V.43 (4). — P.863—876.

Zubkov A.Y., Rollins K.S. Mechanism of endothelin-1-induced contraction in rabbit basilar artery // Stroke. — 2000. — V.31 (2). — P.526—533.

Zubkov A., Lewis A., Raila F. Risk Factors for the Development of Post-Traumatic Cerebral Vasospasm // Surg. Neurol. — 2000. — V.53. — P.126—130.

Zubkov A.Y., Ogihara K., Bernanke D.H. et al. Apoptosis of Endothelial Cells in Vessels Affected by Cerebral Vasospasm // Surg. Neurol. — 2000. — V.53. — P.260—266.

Zuccarello M., Romano A., Passalacgua M., Rapoport R.M. Decreased endothelium-dependent relaxation in subarachnoid hemorrhage-induced vasospasm: Role of ET-1 // Am. J. Physiol. — 1995. — V.269. — P.1009—1015.